Clinical Trial Update: Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)

View source ↗

Summary

This clinical trial update evaluates the efficacy, tolerability, and safety of ALNA in patients with Benign Prostatic Hyperplasia. The trial status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• ALNA (tamsulosin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Status: COMPLETED